AC Immune S.A. (ACIU) vs CAMP4 Therapeutics Corporation (CAMP)
A side-by-side comparison of AC Immune S.A. and CAMP4 Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACIU
AC Immune S.A.
$2.71HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CAMP
CAMP4 Therapeutics Corporation
$4.01HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACIU vs CAMP
growth of $100 · dividends reinvested · last 2yACIU -18.4% (-9.7%/yr)CAMP -62.6% (-38.8%/yr)ACIU compounded faster over this window
ACIU CAMP
ACIU vs CAMP: by the numbers
- •ACIU is the larger company ($276M vs $252M market cap).
- •Both run net losses; ACIU's is the smaller (-249.94% vs -2543.74% net margin).
- •Both shrank revenue over the past five years; ACIU's decline was smaller (-23.70% vs -57.68% CAGR).
Metrics side by side
Valuation
| Metric | ACIU | CAMP |
|---|---|---|
| P/S ratio | 12.71 | 59.69 |
| P/B ratio | 6.34 | N/A |
Profitability
| Metric | ACIU | CAMP |
|---|---|---|
| Gross margin | 100.00% | 53.14% |
| Operating margin | -1927.32% | -1488.31% |
| Net margin | -249.94% | -2543.74% |
| ROE | -124.67% | N/A |
| ROIC | -89.43% | -69.76% |
Growth (annualized)
| Metric | ACIU | CAMP |
|---|---|---|
| Revenue CAGR (5Y) | -23.70% | -57.68% |
| Total return CAGR (5Y) | -16.03% | N/A |
Frequently asked
- Which has grown faster, ACIU or CAMP?
- Neither grew: over the past five years both shrank revenue, with ACIU's decline the smaller — ACIU at a -23.70% CAGR versus CAMP at -57.68%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.